Literature DB >> 16249113

Oral cavity cancers at a young age: analysis of patient, tumor and treatment characteristics in Chiang Mai University Hospital.

Imjai Chitapanarux1, Vicharn Lorvidhaya, Pichit Sittitrai, Thienchai Pattarasakulchai, Ekkasit Tharavichitkul, Pornpoch Sriuthaisiriwong, Pimkhuan Kamnerdsupaphon, Vimol Sukthomya.   

Abstract

Oral cavity cancer is predominantly a disease of middle-aged men who use tobacco and alcohol. Nearly 95% of carcinomas occur after the age of 45, with an average age of approximately 60 years. In recent years, oral cavity cancers have increased at a younger age, especially in females who never consumed alcohol or smoked. The purpose of this study is to provide the information of these cancers in young patients treated in our hospital during a 5-year period. As well as to describe the treatment modalities and their results. We reviewed the medical records of oral cavity cancer patients occurring before the age of 45 who were treated at Chiang Mai University Hospital from 1999 to 2003. All the demographic data, histopathology, treatment modalities and their results were recorded. Follow up range from 0.7 to 4.4 years (mean 2.6 year). A total of 20 patients were studied. There were 12 male (60%) and 8 female (40%). The mean age was 34.4 year (20-40 year). The most common site was oral tongue (15 patients, 75%). Fifty-five percent of patients were stage III and IV. Only 6 patients (30%) were treated by surgery alone, 8 patients (40%) were treated by surgery and post-operative radiotherapy, 4 patients (20%) were subjected to radiotherapy alone, and 2 patients (10%) were treated by radiochemotherapy. The results of primary treatment in all modalities were acceptable with 5 patients (25%) developing loco-regional recurrence of disease within 10.8 months (2-36). At the time of analysis, 13 patients (65%) had no evidence of disease. The demographic data of oral cavity in younger patients in our hospital were different from the elderly, with oral tongue commonly occurring. Most of the patients were locally advanced stage. The results of all treatment modalities provided fair loco-regional control suggested more aggressive treatment in this group of patients.

Entities:  

Mesh:

Year:  2005        PMID: 16249113     DOI: 10.1016/j.oraloncology.2005.06.015

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  14 in total

1.  Oral squamous cell carcinoma among Yemenis: Onset in young age and presentation at advanced stage.

Authors:  Esam Halboub; Maha Al-Mohaya; Mahmoud Abdulhuq; Ahmad Al-Mandili; Yousef Al-Anazi
Journal:  J Clin Exp Dent       Date:  2012-10-01

2.  Galectin-3 accelerates the progression of oral tongue squamous cell carcinoma via a Wnt/β-catenin-dependent pathway.

Authors:  Li-Ping Wang; Shu-Wei Chen; Shi-Min Zhuang; Huan Li; Ming Song
Journal:  Pathol Oncol Res       Date:  2013-03-22       Impact factor: 3.201

3.  A comparison of oral squamous cell carcinoma between young and old patients in a single medical center in China.

Authors:  Qiang Sun; Qigen Fang; Shu Guo
Journal:  Int J Clin Exp Med       Date:  2015-08-15

4.  Clinical outcome of squamous cell carcinoma of the tongue in young patients: a stage-matched comparative analysis.

Authors:  Jun-Ook Park; Dong-Il Sun; Kwang-Jae Cho; Young-Hoon Joo; Hwa-Jong Yoo; Min-Sik Kim
Journal:  Clin Exp Otorhinolaryngol       Date:  2010-09-17       Impact factor: 3.372

Review 5.  Nanotechnology-based drug delivery systems for treatment of oral cancer: a review.

Authors:  Giovana Calixto; Jéssica Bernegossi; Bruno Fonseca-Santos; Marlus Chorilli
Journal:  Int J Nanomedicine       Date:  2014-08-08

Review 6.  Epidemiology of oral cancer in Arab countries.

Authors:  Abeer Al-Jaber; Lubna Al-Nasser; Ashraf El-Metwally
Journal:  Saudi Med J       Date:  2016-03       Impact factor: 1.484

7.  Effect of Chewing Gum on Oral Mucositis in Children Undergoing Chemotherapy: A Randomized Controlled Study.

Authors:  A Eghbali; B Taherkhanchi; B Bagheri; B Sadeghi Sedeh
Journal:  Iran J Ped Hematol Oncol       Date:  2016-03-15

8.  Serum big endothelin-1 as a biomarker in oral squamous cell carcinoma patients: an analytical study.

Authors:  Pritam Kumar Mankapure; Suresh Ramchandra Barpande; Jyoti Dilip Bhavthankar; Manda Mandale
Journal:  J Appl Oral Sci       Date:  2015-10       Impact factor: 2.698

9.  Oral and oropharyngeal squamous cell carcinoma in young adults: A retrospective study in Granada University Hospital.

Authors:  P Cariati; A Cabello-Serrano; M Perez-de Perceval-Tara; F Monsalve-Iglesias; I Martínez-Lara
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2017-11-01

Review 10.  The etiologic spectrum of head and neck squamous cell carcinoma in young patients.

Authors:  Xin Liu; Xiao-Lei Gao; Xin-Hua Liang; Ya-Ling Tang
Journal:  Oncotarget       Date:  2016-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.